Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 6
2005 3
2006 4
2007 7
2008 7
2009 8
2010 4
2011 5
2012 8
2013 6
2014 13
2015 5
2016 5
2017 10
2018 11
2019 10
2020 18
2021 21
2022 20
2023 20
2024 31
2025 23
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean edward awylegala (1 results)?
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Subconjunctival dirofilariasis.
Wylęgała A, Wróblewska-Czajka E, Wylęgała E. Wylęgała A, et al. Among authors: wylegala e. Am J Ophthalmol. 2022 Jan;233:e1. doi: 10.1016/j.ajo.2021.10.016. Epub 2021 Oct 22. Am J Ophthalmol. 2022. PMID: 34695396 No abstract available.
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials.
Danzig CJ, Dinah C, Ghanchi F, Hattenbach LO, Khanani AM, Lai TYY, Shimura M, Abreu F, Arrisi P, Liu Y, Paris LP, Retiere AC, Willis JR, Schlottmann PG; BALATON and COMINO Investigators. Danzig CJ, et al. Ophthalmol Retina. 2025 Sep;9(9):848-859. doi: 10.1016/j.oret.2025.03.005. Epub 2025 Mar 17. Ophthalmol Retina. 2025. PMID: 40107501 Free article. Clinical Trial.
Optimised, Broad NGS Panel for Inherited Eye Diseases to Diagnose 1000 Patients in Poland.
Matczyńska E, Beć-Gajowniczek M, Sivitskaya L, Gregorczyk E, Łyszkiewicz P, Szymańczak R, Jędrzejowska M, Wylęgała E, Krawczyński MR, Teper S, Boguszewska-Chachulska A. Matczyńska E, et al. Among authors: wylegala e. Biomedicines. 2024 Jun 18;12(6):1355. doi: 10.3390/biomedicines12061355. Biomedicines. 2024. PMID: 38927562 Free PMC article.
Intraoperative OCT microscopy in 3D.
Wylęgała A, Sendecki A, Wylęgała E. Wylęgała A, et al. Among authors: wylegala e. Expert Rev Med Devices. 2021 Mar;18(3):221-224. doi: 10.1080/17434440.2021.1898374. Epub 2021 Mar 19. Expert Rev Med Devices. 2021. PMID: 33651642 No abstract available.
Visual Acuity Examination Methodology in Keratoconus.
Nandzik M, Wylęgała E, Wylęgała A, Szkodny D, Roszkowska AM, Wróblewska-Czajka E. Nandzik M, et al. Among authors: wylegala e. J Clin Med. 2023 Dec 11;12(24):7620. doi: 10.3390/jcm12247620. J Clin Med. 2023. PMID: 38137688 Free PMC article. Review.
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.
Bressler SB, Barve A, Ganapathi PC, Beckmann K, Apte RS, Marcus DM, Baumane K, Agarwal S, Oleksy P, Reichstein DA, Patel SS, Ernest J, Dégi R, Gupta V, Kishino G, Kamei M, Loganathan S; INSIGHT Study Group. Bressler SB, et al. JAMA Ophthalmol. 2024 Oct 1;142(10):952-960. doi: 10.1001/jamaophthalmol.2024.3458. JAMA Ophthalmol. 2024. PMID: 39264599 Free PMC article. Clinical Trial.
Bilateral Corneal and Conjunctival Melanosis.
Wylęgała A, Pająk J, Wylęgała E. Wylęgała A, et al. Among authors: wylegala e. Am J Ophthalmol. 2024 Aug;264:e5-e6. doi: 10.1016/j.ajo.2024.05.005. Epub 2024 May 18. Am J Ophthalmol. 2024. PMID: 38763498 No abstract available.
241 results